INSY
Geode Capital Management’s Insys Therapeutics, Inc. INSY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-336,136
| Closed | -$1.55M | – | 4268 |
|
2019
Q1 | $1.55M | Buy |
336,136
+15,822
| +5% | +$73.1K | ﹤0.01% | 2988 |
|
2018
Q4 | $1.12M | Buy |
320,314
+8,064
| +3% | +$28.2K | ﹤0.01% | 3064 |
|
2018
Q3 | $3.15M | Buy |
312,250
+10,502
| +3% | +$106K | ﹤0.01% | 2648 |
|
2018
Q2 | $2.18M | Buy |
301,748
+51,033
| +20% | +$369K | ﹤0.01% | 2806 |
|
2018
Q1 | $1.51M | Buy |
250,715
+5,050
| +2% | +$30.5K | ﹤0.01% | 2917 |
|
2017
Q4 | $2.36M | Sell |
245,665
-11,653
| -5% | -$112K | ﹤0.01% | 2654 |
|
2017
Q3 | $2.28M | Buy |
257,318
+5,120
| +2% | +$45.4K | ﹤0.01% | 2668 |
|
2017
Q2 | $3.19M | Sell |
252,198
-52,846
| -17% | -$668K | ﹤0.01% | 2450 |
|
2017
Q1 | $3.21M | Buy |
305,044
+26,913
| +10% | +$283K | ﹤0.01% | 2382 |
|
2016
Q4 | $2.56M | Buy |
278,131
+95,291
| +52% | +$876K | ﹤0.01% | 2494 |
|
2016
Q3 | $2.16M | Buy |
182,840
+839
| +0.5% | +$9.89K | ﹤0.01% | 2520 |
|
2016
Q2 | $2.35M | Buy |
182,001
+4,536
| +3% | +$58.7K | ﹤0.01% | 2373 |
|
2016
Q1 | $2.84K | Buy |
177,465
+10,861
| +7% | +$174 | ﹤0.01% | 2220 |
|
2015
Q4 | $4.77M | Sell |
166,604
-6,847
| -4% | -$196K | ﹤0.01% | 1908 |
|
2015
Q3 | $4.94M | Buy |
173,451
+25,186
| +17% | +$717K | ﹤0.01% | 1855 |
|
2015
Q2 | $5.33M | Buy |
148,265
+78,790
| +113% | +$2.83M | ﹤0.01% | 1844 |
|
2015
Q1 | $4.04M | Buy |
69,475
+4,487
| +7% | +$261K | ﹤0.01% | 1989 |
|
2014
Q4 | $2.74M | Buy |
64,988
+7,581
| +13% | +$320K | ﹤0.01% | 2233 |
|
2014
Q3 | $2.23M | Buy |
57,407
+11,582
| +25% | +$449K | ﹤0.01% | 2299 |
|
2014
Q2 | $1.43M | Sell |
45,825
-10,421
| -19% | -$325K | ﹤0.01% | 2584 |
|
2014
Q1 | $2.33M | Sell |
56,246
-4,181
| -7% | -$173K | ﹤0.01% | 2246 |
|
2013
Q4 | $2.34M | Buy |
60,427
+22,910
| +61% | +$886K | ﹤0.01% | 2202 |
|
2013
Q3 | $1.31M | Buy |
37,517
+16,070
| +75% | +$562K | ﹤0.01% | 2442 |
|
2013
Q2 | $297K | Buy |
+21,447
| New | +$297K | ﹤0.01% | 3090 |
|